Celanese Corporation Overview
Celanese is a US-headquartered chemical and specialty materials company with two businesses. Engineered Materials sells specialty polymers such as POM, nylon, PBT, LCP, UHMW-PE and elastomers into automotive, electronics, medical and industrial applications. The Acetyl Chain is among the world's largest and lowest-cost producers of acetic acid, vinyl acetate monomer and their downstream derivatives. The USD 11 billion acquisition of DuPont's Mobility & Materials business in 2022 doubled the engineered-materials franchise but left the company with about USD 12.6 billion of debt just as demand weakened. That has produced two consecutive years of multi-billion-dollar goodwill and trade-name impairments, a 95% dividend cut and the loss of investment-grade ratings. Under CEO Scott Richardson, in post since January 2025, the agenda is cash generation, cost reduction, divestitures and footprint closures. The equity is a highly leveraged recovery situation: second-quarter 2026 earnings were the strongest in nearly three years, helped partly by temporary supply dislocations.
The company's own description (paraphrased from the FY2025 10-K, Item 1). Celanese describes itself as a global chemical and specialty materials company. It is a global producer of high-performance engineered polymers and one of the world's largest producers of acetyl products, which are intermediates for nearly all major industries. Its end-uses include automotive, chemical additives, construction, adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. It attributes its leading positions to differentiated business models, large global capacity, operating efficiency, proprietary technology and a competitive cost structure. Operations comprise 51 production facilities plus 20 strategic-affiliate production facilities, mainly in North America, Europe and Asia.
Independent characterisation. Celanese is best understood as two distinct businesses under one leveraged balance sheet:
-
Acetyl Chain (44% of FY2025 net sales). This is an integrated commodity-to-intermediate chain: methanol, acetic acid, VAM, then emulsions, redispersible powders and EVA polymers, plus acetate tow. Its advantage is cost position, built on US Gulf Coast natural gas, the Clear Lake complex, the Fairway methanol joint venture and proprietary AOPlus and VAntage process technologies. It also has the optionality to move molecules between products and regions to wherever margin is highest. Pricing follows industry utilisation and raw-material costs, with lags of months to quarters.
-
Engineered Materials (56% of FY2025 net sales). This is a project-based specialty polymers business. Materials are specified into customer parts through an opportunity pipeline. Pricing is primarily value-in-use and largely independent of raw-material cost in the short run, so margins expand or contract as input costs move.
Revenue model. Revenue is essentially 100% product sales, covering chemicals and polymers sold by volume. There is no material subscription, service or licensing revenue line, although process technology has been licensed historically. A significant share of earnings comes from non-consolidated affiliates. In FY2025, equity in net earnings of affiliates was USD 127 million and dividend income from cost-method investments was USD 122 million, mainly from the three Chinese acetate tow ventures with China National Tobacco Corporation (FY2025 earnings release).
Value chain position. The company is upstream-integrated in acetyls, with self-supply of methanol in North America through Fairway and captive acetic acid, VAM and formaldehyde. In Engineered Materials it is midstream, covering polymerisation and compounding. It sells to OEMs, tier suppliers, moulders, formulators and distributors.
Customer types. Engineered Materials sells to OEMs and their suppliers in automotive, medical, industrial and consumer markets under multi-year and annual arrangements, plus distributors. The Acetyl Chain sells to producers of paints, coatings, adhesives, polyesters, pharmaceuticals and construction products under a mix of short- and long-term agreements. Acetate tow is sold to the major tobacco companies, often on multi-year pricing.
End-markets. Automotive (including electric and hybrid drivetrains), electrical and electronics (connectors, AI-server components), medical devices and drug delivery, construction, paints and coatings, adhesives, packaging, filtration (cigarette filters), energy storage (battery separators) and consumer goods.
Strategy
Stated strategy themes (paraphrased from the FY2025 release, 2026 proxy letters and Q2 2026 prepared comments). Management repeats three priorities:
-
Increase cash flow to accelerate deleveraging.
-
Intensify cost improvements.
-
Drive top-line growth.
The CEO's shareholder letter calls stronger free cash flow the company's most important financial objective.
Initiative register (last 24 months)
Named growth platforms with company-estimated opportunity (Q2 2026 prepared comments)
Guidance and medium-term targets
No formal investor day with multi-year targets was identified in the past 24 months.
Products & Services
Pricing is not publicly disclosed at product level. EM products are priced on value-in-use; AC products track utilisation and raw materials. Launch years are generally not disclosed for these long-established product families. Descriptions follow the FY2025 10-K, Item 1.
Engineered Materials
| Product family | Brands | Description and capabilities | Main customers and applications |
|---|---|---|---|
| Polyoxymethylene (POM / acetal copolymer) | Hostaform, Celcon; Amcel; Kepital via the KEP venture | High stiffness, low friction and fatigue resistance. Range includes low-emission, high-impact, wear-resistant, laser-markable and metallic-effect grades. Formaldehyde feedstock is made in-house from methanol | Fuel-system parts, window lifts, conveyor belts, sprinklers, drug-delivery devices, appliance gears |
| Sustainable POM | POM ECO-B (bio-mass balance); POM ECO-C (carbon-capture content, ISCC carbon footprint certification announced Dec 2025) | Mass-balance grades that reduce product carbon footprint | OEMs with renewable-content targets |
| Nylon (polyamide) compounds | Zytel (PA6, PA66, PA610, PA612), Zytel HTN (PPA), Zytel long-chain polyamides, Celanyl, FRIANYL (flame-retardant), ECOMID (recycled), NILAMID | Mechanical strength, dimensional stability, heat and fatigue resistance. Zytel is the flagship acquired with M&M, and its trade name was impaired in 2024 and 2025 | Automotive under-hood, electrical and electronic connectors, appliances, industrial, consumer |
| Thermoplastic polyesters | Celanex PBT, Crastin PBT, Rynite PET, Thermx PCT | Electrical insulation, heat resistance and dimensional stability | Ignition parts, switches, sensor housings, LEDs, photovoltaic components, medical devices |
| Liquid crystal polymers | Vectra, Zenite | Thin-wall precision moulding and heat dissipation | High-speed connectors, electronic components, high-heat cookware |
| Long-fibre reinforced thermoplastics | Celstran | Extra strength and stiffness for larger structural parts; a metal-replacement material | Instrument panels, consoles, front-end modules |
| Ultra-high molecular weight polyethylene | GUR | Engineered polyethylene powders | Lead-acid and lithium-ion battery separators, filtration, medical implants, industrial wear parts |
| Thermoplastic vulcanizates | Santoprene, Geolast | Cross-linked elastomer and thermoplastic hybrids | Automotive sealing, future mobility, infrastructure, medical |
| Thermoplastic elastomers | Hytrel (copolyester), Sofprene T, Laprene, Forprene | Flexibility with plastics processability | Automotive, construction, appliances, consumer |
| Ethylene acrylic elastomers | Vamac | Resistance to extreme temperatures and fluids | Demanding automotive parts including EV and hybrid components |
| Polypropylene compounds | Polifor, Tecnoprene | Impact and fatigue resistance, rigidity at temperature | Automotive, appliances, electrical |
| Pharmaceutical EVA | VitalDose | Controlled-release excipient platform | Drug-eluting implants, ophthalmic devices |
| PPS (via affiliate) | Fortron (Fortron Industries LLC, 50%) | Heat- and chemical-resistant polymer | Automotive, industrial |
| Composite and utility technologies | TufCOR, MetaLX and other named technologies | Composite cores for transmission lines; metallic-effect polymers | Utilities, oil and gas, OEMs |
| Polyester films (via affiliates) | Mylar, Melinex | PET films | Consumer, industrial, healthcare, electronics |
| Filaments (70% ventures) | Tynex and related | Nylon and PBT filaments | Personal care (brush filaments), industrial |
| Digital service | Chemille / AskChemille.com (launched 2025) | AI-enabled digital assistant for material selection | Design engineers and moulders |
Divested: Micromax electronic inks and pastes, sold 2 February 2026 for about USD 500 million. Food ingredients (Sunett acesulfame-K and Nutrinova sorbates) sit in the Nutrinova venture, where Celanese's stake falls to 11% after the pending sale.
Acetyl Chain
| Product family | Brands and technology | Description | Main customers and applications |
|---|---|---|---|
| Acetic acid | AOPlus 3 process technology | Core intermediate made from methanol and carbon monoxide; used captively and sold to third parties | VAM, purified terephthalic acid, anhydride, esters |
| Vinyl acetate monomer (VAM) | VAntage 2 technology | Made from acetic acid and ethylene; feedstock for emulsions and EVA | Adhesives, paints, films, coatings, textiles |
| Acetic anhydride | — | Feedstock for cellulose acetate, detergents and pharmaceuticals | Captive tow production; pharma |
| Acetate esters | Ethyl acetate, butyl acetate | Solvents | Inks, coatings, adhesives, pharmaceuticals, fragrances |
| Formaldehyde and paraformaldehyde | — | Captive for POM, plus regional sales | Wood resins, coatings, polyurethane intermediates |
| Methanol | Fairway Methanol LLC (50% with Mitsui); ECO-CC low-carbon methanol from the Clear Lake carbon capture unit (launched 2025) | Covers almost all North American methanol needs | Captive; carbon-capture-content derivative products |
| Emulsion polymers (VAE and conventional) | EcoVAE, Mowilith, Vinamul, Celvolit, Dur-O-Set, Avicor, Flexbond, Resyn | Vinyl- and acrylate-based emulsions; enable low-VOC paints | Architectural coatings, adhesives, nonwovens, glass fibre, paper |
| Redispersible powders | Elotex | Polymer powders made from emulsions | Tile adhesives, exterior insulation systems, self-levelling floors, renders |
| EVA polymers and LDPE | Ateva | Specialty EVA resins and compounds from high-pressure reactors | Flexible packaging, lamination films, hot-melt adhesives, automotive, carpet |
| Acetate tow and flake | — | Cellulose acetate fibre made from wood pulp, acetic acid and anhydride | Cigarette filters (major tobacco companies) |
| Sustainable acetyls | ECO-CC, ECO-B | Mass-balance carbon-capture and bio-based content across the chain | Coatings and adhesives customers |
Financial Narrative
Income statement
Net sales compound annual growth, FY2021 to FY2025: +2.8%. This is entirely acquisition-driven; sales have fallen 13% from the FY2023 peak.
Balance sheet (at 31 December)
Cash flow
Ratios (analyst calculations unless noted)
Recent quarterly trend (earnings releases and Non-GAAP supplements)
Commentary
Revenue: The step-up from USD 8.5 billion to USD 10.9 billion between FY2021 and FY2023 reflects the M&M acquisition (two months in FY2022, a full year in FY2023) and Santoprene. It masks underlying erosion. Company-wide price fell 4% in each of FY2024 and FY2025, and volume fell 1% and then 4%. Management attributes FY2025 weakness to below-normal demand in automotive, paints, coatings and construction, and to competitive pressure in acetate tow.
Profitability: Gross margin has compressed every year, from 31.4% to 20.5%. FY2021 was a cyclical peak for acetyl spreads. Lower-margin M&M sales diluted the mix, and acetyl and tow pricing has since deflated. GAAP operating results in FY2024 and FY2025 are dominated by non-cash impairments. Asset impairments within Certain Items were USD 1,638 million in FY2024 and USD 1,513 million in FY2025, mainly EM goodwill and the Zytel trade name. The FY2025 goodwill charge alone was USD 1.1 billion. Operating EBITDA fell 20% in FY2025 to USD 1,893 million.
Earnings quality: Adjusted EPS excludes Certain Items but includes about USD 0.35–0.36 per share per quarter of non-cash transaction amortisation. The adjusted tax rate is unusually low at 8–9%. Net earnings in FY2022 and FY2023 were inflated by large deferred-tax benefits from post-acquisition restructuring†.
Inflection: Q2 2026 operating EBITDA of USD 649 million was up more than 20% year on year. Drivers were pricing (+14% sequentially), Middle East supply dislocations benefiting the Acetyl Chain and mix in EM. Management has said explicitly that part of this is non-recurring.
Balance sheet: Total debt has barely moved since FY2024 (USD 12.6 billion). Deleveraging so far has come through cash build and refinancing, not gross debt paydown. That changed in mid-2026: about USD 908 million of 2026 bonds were repaid from cash (USD 508 million in June and USD 400 million in August). Net debt to operating EBITDA worsened to 6.0x at FY2025 because EBITDA fell. Equity has been cut from USD 7.1 billion to USD 4.0 billion by impairments.
Cash flow: Free cash flow recovered to USD 773 million in FY2025. Capex fell to USD 343 million, EM inventory was reduced by more than USD 100 million and cost savings exceeded USD 120 million. The near-elimination of the dividend saves roughly USD 290 million per year, and buybacks have been paused since 2022.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Engineered Materials net sales (USD Mn; FY2023 as originally reported †) | 6,149 | 5,595 | 5,390 |
Acetyl Chain net sales (USD Mn; FY2023 as originally reported †) | 4,884 | 4,763 | 4,232 |
Intersegment eliminations (USD Mn; FY2023 †) | -93 | -90 | -78 |
Total net sales (USD Mn; FY2023 on the originally reported basis; revised FY2023 total is 10926) | 10,940 | 10,268 | 9,544 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Engineered Materials operating profit (USD Mn; FY2023 †) | 1,083 | -1,197 | -958 |
Acetyl Chain operating profit (USD Mn; FY2023 †) | 1,109 | 946 | 539 |
Other Activities operating profit (USD Mn; FY2023 †) | -505 | -469 | -367 |
Total operating profit (USD Mn; FY2023 as originally reported †) | 1,687 | -720 | -786 |
Segment Margins & Growth (%) and Results by Segment
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
EM operating margin (%) | 17.6 | -21.4 | -17.8 |
AC operating margin (%) | 22.7 | 19.9 | 12.7 |
EM adjusted EBIT (USD Mn) | — | 841 | 720 |
AC adjusted EBIT (USD Mn) | — | 1,097 | 695 |
EM adjusted EBIT margin (%) | — | 15.0 | 13.4 |
AC adjusted EBIT margin (%) | — | 23.0 | 16.4 |
EM operating EBITDA (USD Mn) | — | 1,278 | 1,161 |
AC operating EBITDA (USD Mn) | — | 1,341 | 947 |
EM net sales growth YoY (%) | — | -9.0 | -3.7 |
AC net sales growth YoY (%) | — | -2.5 | -11.1 |
EM share of total net sales (%) | 56.2 | 54.5 | 56.5 |
AC share of total net sales (%) | 44.6 | 46.4 | 44.3 |
Revenue by Segment (%) and Segment Margins & Growth (%)
| Driver | FY2024 | FY2025 |
|---|---|---|
EM volume effect on net sales (%) | -5 | -4 |
EM price effect on net sales (%) | -3 | -1 |
AC volume effect on net sales (%) | 4 | -6 |
AC price effect on net sales (%) | -6 | -6 |
Total company net sales change (%) | -6 | -7 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net sales (USD Mn) | 8,537 | 9,673 | 10,926 | 10,268 | 9,544 |
Gross profit (USD Mn) | 2,682 | 2,380 | 2,583 | 2,336 | 1,952 |
Operating profit (USD Mn; FY2021–FY2023 as originally reported †) | 1,946 | 1,378 | 1,687 | -720 | -786 |
Operating EBITDA, company-defined (USD Mn; FY2021–FY2022 †; FY2023 as published March 2025) | 2,803 | 2,708 | 2,444 | 2,353 | 1,893 |
Pre-tax income, continuing operations (USD Mn; FY2021–FY2023 †) | 2,248 | 1,421 | 1,183 | -1,019 | -1,220 |
Net earnings attributable to Celanese (USD Mn) | 1,890 | 1,894 | 1,943 | -1,542 | -1,165 |
Diluted EPS, continuing operations (USD; FY2021 and FY2023 as originally reported †) | 16.99 | 17.41 | 18.00 | -14.04 | -10.44 |
Basic EPS, continuing operations (USD) | — | — | — | -14.04 | -10.44 |
Adjusted EPS (USD; FY2021 and FY2023 †) | 18.12 | 15.88 | 8.92 | 8.18 | 3.98 |
Dividends per share (USD; FY2021–FY2024 †) | 2.72 | 2.72 | 2.80 | 2.80 | 0.12 |
Gross margin (%) | 31.4 | 24.6 | 23.6 | 22.8 | 20.5 |
Operating margin (%) | 22.8 | 14.2 | 15.4 | -7.0 | -8.2 |
Operating EBITDA margin (%) | 32.8 | 28.0 | 22.4 | 22.9 | 19.8 |
Net margin (%) | 22.1 | 19.6 | 17.8 | -15.0 | -12.2 |
Research and development expense (USD Mn; FY2021–FY2023 †) | 86 | 112 | 146 | 130 | 125 |
Interest expense (USD Mn; FY2021–FY2023 †) | 91 | 405 | 720 | 676 | 701 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (USD Mn; FY2021–FY2023 †) | 11,975 | 26,272 | 26,597 | 22,838 | 21,695 |
Cash and equivalents (USD Mn; FY2021–FY2023 †) | 536 | 1,508 | 1,805 | 962 | 1,263 |
Short-term debt (USD Mn; FY2021–FY2022 †) | 791 | 1,306 | 1,383 | 1,501 | 1,204 |
Long-term debt (USD Mn; FY2021–FY2022 †) | 3,176 | 13,373 | 12,301 | 11,078 | 11,394 |
Total debt (USD Mn) | 3,967 | 14,679 | 13,684 | 12,579 | 12,598 |
Net debt (USD Mn) | 3,431 | 13,171 | 11,879 | 11,617 | 11,335 |
Celanese shareholders' equity (USD Mn; FY2021–FY2022 †) | 4,189 | 5,637 | 7,065 | 5,129 | 4,049 |
Goodwill (USD Mn; FY2021–FY2023 †) | 1,412 | 7,142 | 6,977 | 5,387 | 4,171 |
Intangible assets, net (USD Mn) | 735 | 4,105 | 3,975 | 3,641 | 3,184 |
Working capital, current assets less current liabilities (USD Mn) | — | — | — | 1,236 | 2,010 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (USD Mn; FY2021–FY2022 †) | 1,757 | 1,819 | 1,899 | 966 | 1,146 |
Capital expenditure (USD Mn; FY2021–FY2023 †) | 467 | 543 | 568 | 435 | 343 |
Operating cash flow less capex (USD Mn, analyst calculation) | 1,290 | 1,276 | 1,331 | 531 | 803 |
Free cash flow, company-defined (USD Mn) | — | — | 1,320 | 498 | 773 |
Dividends paid (USD Mn, estimated as DPS × average shares) | 304 | 297 | 305 | 306 | 13 |
Share repurchases (USD Mn; †) | 1,000 | 17 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Return on equity (%) | 49.0 | 38.6 | 30.6 | -25.3 | -25.4 |
Return on assets (%) | 16.5 | 9.9 | 7.4 | -6.2 | -5.2 |
Return on invested capital, adjusted, company-defined (%) | — | — | — | 7.7 | 6.2 |
Current ratio (x) | — | — | — | 1.32 | 1.55 |
Total debt / equity (x) | 0.95 | 2.60 | 1.94 | 2.45 | 3.11 |
Net debt / operating EBITDA (x) | 1.22 | 4.86 | 4.86 | 4.94 | 5.99 |
Operating EBITDA / interest expense (x) | 30.8 | 6.7 | 3.4 | 3.5 | 2.7 |
Asset turnover (x) | 0.75 | 0.51 | 0.41 | 0.42 | 0.43 |
Cash conversion cycle (days) | — | — | — | 88 | 81 |
Income Statement and Per-Share Data (Quarterly)
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
Net sales (USD Mn; 2026 quarters rounded from USD 2.3 billion and USD 2.8 billion) | 2,389 | 2,532 | 2,419 | 2,204 | 2,300 | 2,800 |
Adjusted EBIT (USD Mn) | 231 | 342 | 326 | 251 | 275 | 470 |
Operating EBITDA (USD Mn) | 411 | 530 | 517 | 435 | 455 | 649 |
Adjusted EPS (USD) | 0.54 | 1.43 | 1.34 | 0.67 | 0.85 | 2.45 |
Free cash flow (USD Mn) | -73 | 311 | 375 | 160 | 3 | 140 |
Revenue by Region
| Country | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United States (USD Mn) | 2,807 | 2,736 | 2,568 |
Germany (USD Mn) | 2,468 | 2,201 | 750 |
Greater China (USD Mn) | 1,952 | 1,984 | 1,792 |
Singapore (USD Mn; FY2023–FY2024 rounded from aggregator data) | 1,150 | 1,000 | 707 |
Mexico (USD Mn) | 361 | 344 | 243 |
Belgium (USD Mn; aggregator data) | 499 | 400 | — |
Switzerland (USD Mn; aggregator data) | 223 | 294 | — |
Japan (USD Mn; aggregator data) | 312 | 278 | — |
Region Margins & Growth (%)
| Country | FY2024 | FY2025 |
|---|---|---|
United States growth (%) | -2.5 | -6.1 |
Germany growth (%) | -10.8 | -65.9 |
Greater China growth (%) | 1.6 | -9.7 |
Mexico growth (%) | -4.7 | -29.4 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (USD; FY2021–FY2023 †; FY2025 derived from reported year-to-date changes) | 168.06 | 102.24 | 155.37 | 69.21 | 42.28 |
Annual price change (%) | — | -39.2 | 52.0 | -55.5 | -38.9 |
Performance to About 2 Oct 2026 Details
| Performance to about 2 Oct 2026 (price about USD 44.2–44.8) | Value |
|---|---|
2026 year to date | about +5% |
52-week range | USD 35.13–70.70 |
3-year | about -60% to -65% (approximate, †) |
5-year | about -70% to -75% (approximate, †) |
Valuation Multiples
| Multiple | Basis | Value |
|---|---|---|
P/E | Price about USD 44.5 on FY2026 adjusted EPS guidance of about USD 6.00 | about 7.4x |
EV/EBITDA | Enterprise value about USD 16 billion (market cap about USD 4.9 billion, estimated net debt about USD 10.7 billion, non-controlling interests about USD 0.4 billion) on trailing-twelve-month operating EBITDA of about USD 2.06 billion | about 7.8x |
EV/Sales | On trailing-twelve-month sales of about USD 9.7 billion | about 1.6x |
P/B | Book equity of USD 4,049 million at year-end 2025, about USD 37 per share | about 1.2x |
Source Details
| Source | Rating | Average target (USD) |
|---|---|---|
Yahoo Finance | — | 63.12 (range 45–86) |
StockAnalysis (16 analysts) | Buy | 63.63 |
MarketBeat | Hold | about 56–60 |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends per share (USD; FY2021–FY2024 †) | 2.72 | 2.72 | 2.80 | 2.80 | 0.12 |
Credit Ratings
| Agency | Rating | Outlook | Last action |
|---|---|---|---|
Moody's | Ba2 corporate family rating | Negative | Downgraded from Ba1 in November 2025 |
S&P Global | Sub-investment grade; downgraded November 2025 | — | — |
Fitch | BBB- with negative outlook in March 2025 | — | — |
Analyst Conclusions
Management guidance. FY2026 adjusted EPS of about USD 6.00 and free cash flow of USD 700–800 million. First-half adjusted EPS totalled USD 3.30, so guidance implies about USD 2.70 for the second half: a third quarter of USD 1.35–1.75 and a fourth quarter of roughly USD 1.0–1.3. Second-half headwinds include about USD 45 million of EM inventory effects from footprint actions, Lanaken inventory effects, raw-material cost catch-up in EM and lower Ibn Sina income. Working capital absorbed USD 178 million in the second quarter and is expected to unwind in the second half and into 2027.
Consensus. Average price targets of about USD 56–64 imply 25–45% upside. Ratings are split between Hold and Buy.
Bull case
-
Deleveraging is now visible. About USD 908 million of bonds were repaid in mid-2026, USD 652 million of divestitures are announced, and free cash flow is running at USD 700–800 million. Net debt could approach USD 10 billion by year-end, taking leverage toward 5x or below on trailing EBITDA.
-
Earnings power was demonstrated. Acetyl Chain operating EBITDA of USD 385 million in one quarter shows what the asset base earns when utilisation tightens. EM adjusted EBIT has been stable at about USD 190–235 million a quarter with growth platforms compounding.
-
Valuation. About 7.4x guided 2026 adjusted EPS and a free cash flow yield near 15% on the equity leave room for re-rating as interest expense falls and cost savings of USD 190–230 million flow through.
Bear case
-
2026 is flattered. Management says supply-related gains will not recur. Stripping them out, the run-rate may be closer to the USD 0.67–1.34 per quarter of late 2025, about USD 4 annualised.
-
The balance sheet leaves no margin for error. Leverage was 6.0x at year-end 2025, coupons are above 7%, the Moody's outlook is negative, and equity cover is thin after USD 3.1 billion of impairments. A cyclical relapse could force dilutive action or distressed asset sales.
-
Structural pressure. Chinese overcapacity in acetyls and nylon, declining acetate tow, flat global auto builds and low reinvestment (R&D 1.3% of sales, capex below half of depreciation) may erode competitive position while cash is diverted to creditors.
Catalysts and monitorables (next 12 months)
Analyst verdict. Celanese is a good pair of businesses carrying a poor balance sheet, and the investment case turns almost entirely on how fast the second problem can be fixed before the first is tested again. The Acetyl Chain remains an advantaged franchise. It earned a 22% operating EBITDA margin in a trough year, and when supply tightened in 2026 it captured the upside faster than competitors. Engineered Materials is a credible specialty portfolio whose economics were obscured by an overpriced, debt-funded acquisition closed at the top of the cycle. Two rounds of impairment have now recognised that error on the books.
Management under Scott Richardson has done what a leveraged company should do: cut the dividend, cut capital spending, close high-cost plants, sell non-core assets at good multiples and repay maturing bonds with cash. The evidence so far is supportive. Free cash flow was USD 773 million in 2025, the 2026 target has been raised, and the divestiture programme is about two-thirds complete.
The caution is that 2026 earnings include a geopolitical windfall that management itself says will not repeat. The underlying demand picture in automotive, construction and coatings has not improved. On a normalised basis the company probably earns USD 4–5 per share, not USD 6, and leverage remains near 5x even after this year's progress. With coupons above 7%, a negative rating outlook and low reinvestment in R&D and plant, a renewed downturn in 2027 would be difficult to absorb.
The credit story is improving faster than the equity narrative. The next two quarters matter most: they will show how much of the 2026 gain in price, share and customer relationships survives once supply conditions normalise.
Verification note.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Age | Title | Tenure and background |
|---|---|---|---|
Scott A. Richardson | 49 | President, CEO and Director | CEO since 1 Jan 2025. Previously EVP and COO (2023–2024), EVP and CFO (2018–2023), SVP Engineered Materials (2015–2018), VP Acetyl Intermediates (2011–2015). Joined Celanese in 2005 from American Airlines. BA Accounting, Westminster College; MBA, Texas Christian University |
Chuck B. Kyrish | 54 | SVP and Chief Financial Officer | CFO since November 2023. BS, University of Texas at Austin; MBA, Texas Christian University |
Mark C. Murray | 55 | SVP, Acetyls | In role since February 2023; interim leader from November 2022 |
Todd Elliott | 60 | SVP, Engineered Materials | — |
Ashley B. Duffie | 51 | SVP, General Counsel and Corporate Secretary | — |
Directors' Remuneration
| Executive | Salary (USD) | Stock awards (USD) | Option awards (USD) | Non-equity incentive (USD) | All other (USD) | Total (USD) |
|---|---|---|---|---|---|---|
Scott A. Richardson | about 1.15 million | about 5.25 million | about 2.25 million | about 1.34 million | about 0.14 million | about 10.14 million |
Other named executives | not captured | not captured | not captured | not captured | not captured | not captured |
Board of Directors
| Director | Age | Since | Independent | Role and committees | Background |
|---|---|---|---|---|---|
Edward G. Galante | 75 | 2013 | Yes | Chair of the Board; Finance and Business Review | Former SVP, ExxonMobil; director, Clean Harbors. Retirement-age guideline waived for 2026 |
Bruce E. Chinn | 69 | 2024 | Yes | Finance and Business Review (co-chair); Audit; Stewardship | Former CEO, Chevron Phillips Chemical; director, Waste Management |
Kathryn M. Hill | 69 | 2015 | Yes | Stewardship (chair); Compensation | Former SVP, Cisco Systems |
Deborah J. Kissire | 68 | 2020 | Yes | Audit (chair); Nominating and Governance | Former Vice Chair, Ernst & Young; director at Axalta, Omnicom, Cable One |
Michael Koenig | 62 | 2022 | Yes | Compensation; Stewardship | CEO, Nobian; Chair, Symrise; former CEO of Elkem and China National Bluestar |
Christopher J. Kuehn | 53 | 2025 | Yes | Audit; Finance and Business Review | EVP and CFO, Trane Technologies |
Ganesh Moorthy | 66 | 2023 | Yes | Compensation (chair); Nominating and Governance | Former CEO, Microchip Technology |
Kim K.W. Rucker | 59 | 2018 | Yes | Nominating and Governance (chair); Compensation | Former EVP and General Counsel, Andeavor; director at Marathon Petroleum, HP, GE Vernova |
Scott A. Richardson | 49 | 2025 | No | Finance and Business Review (co-chair) | CEO |
Luis Fernandez-Moreno | — | Sept 2026 | — | — | — |
Board & Management Changes
| Date | Change |
|---|---|
1 Jan 2025 | Richardson succeeds Lori Ryerkerk as CEO; Galante becomes independent Chair |
| 2025 | Christopher Kuehn and Scott Sutton join the board |
6 Jan 2026 | Scott Sutton resigns from the board on taking a CEO role elsewhere |
16 Apr 2026 | David Hoffmeister and Jay Ihlenfeld do not stand for re-election; board reduced from 11 to 9. All nine nominees elected with an 88.5% quorum |
16 Sep 2026 | Luis Fernandez-Moreno elected to the board |
Major Shareholders
| Holder | Shares | % of class |
|---|---|---|
Dodge & Cox | 15,391,416 | 13.75 |
BlackRock, Inc. | 12,529,017 | 11.19 |
The Vanguard Group | 12,003,709 | 10.72 |
Capital International Investors | 7,434,001 (6.65% in the 2025 proxy) | Not listed as a holder above 5% in the 2026 proxy |
All directors and executive officers as a group | — | 0.34 |
Scott A. Richardson | 140,621 (including rights to acquire) | 0.13 |
Competitive Landscape
Competitors by Segment
| Business | Named competitors |
|---|---|
Acetic acid and VAM | INEOS Acetyls, LyondellBasell, Eastman Chemical, Dow (VAM), Wacker Chemie (VAM/VAE), Kuraray, Chinese producers (for example Jiangsu Sopo, Hualu-Hengsheng, Sinopec affiliates), Sipchem and other Middle East producers |
Emulsions and redispersible powders | Wacker Chemie, Dow, BASF, Synthomer, Dairen Chemical |
Acetate tow | Eastman Chemical, Daicel, Cerdia, Chinese tobacco-affiliated producers |
POM | Polyplastics (Daicel), Delrin (TJC-owned), BASF, Asahi Kasei, Mitsubishi Engineering-Plastics, Kolon, Chinese entrants |
Nylon and PPA | BASF, Envalior (former DSM and Lanxess engineering plastics), Ascend Performance Materials, Invista, Syensqo/Solvay, EMS-Chemie, Toray, DOMO, Kingfa |
PBT, PET and LCP | BASF, Envalior, SABIC, Toray, Polyplastics, Sumitomo Chemical (LCP), Syensqo |
Elastomers | Dow, ExxonMobil, Mitsui Chemicals, Envalior (Arnitel), Kraton, Teknor Apex |
UHMW-PE | Braskem, Asahi Kasei, Mitsui Chemicals, LyondellBasell |
Peer Comparison FY2025
| Metric | Celanese (FY2025) | Eastman Chemical (FY2024 †) | DuPont (FY2024 †) | BASF (FY2024 †) |
|---|---|---|---|---|
Revenue | USD 9.5 billion | about USD 9.4 billion | about USD 12.4 billion | about EUR 65.3 billion |
Revenue growth | -7% | about +2% | about +3% | about -5% |
EBITDA margin (company definitions differ) | 19.8% operating EBITDA | about 19–20% adjusted | about 25% operating EBITDA | about 12% before special items |
R&D intensity | 1.3% | about 2.5–3% | about 4% | about 3% |
Net debt / EBITDA | 6.0x | about 2.5x | about 1.5–2x | about 2.5x |
